Changes in thalamic connectivity in the early and late stages of amnestic mild cognitive impairment: a resting-state functional magnetic resonance study from ADNI.

Changes in thalamic connectivity in the early and late stages of amnestic mild cognitive impairment: a resting-state functional magnetic resonance study from ADNI.

We used resting-state functional magnetic resonance imaging (fMRI) to investigate changes in the thalamus functional connectivity in early and late stages of amnestic mild cognitive impairment. Data of 25 late stages of amnestic mild cognitive impairment (LMCI) patients, 30 early stages of amnestic...

Full description

Bibliographic Details
Main Authors:	Suping Cai, Liyu Huang, Jia Zou, Longlong Jing, Buzhong Zhai, Gongjun Ji, Karen M von Deneen, Junchan Ren, Aifeng Ren, Alzheimer’s Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4332494?pdf=render

Similar Items

Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI.
by: Xiuhua Ding, et al.
Published: (2019-01-01)

Altered functional connectivity of fusiform gyrus in subjects with amnestic mild cognitive impairment: a resting state fMRI study
by: SuPing eCai, et al.
Published: (2015-08-01)

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment
by: Cosimo Tuena, et al.
Published: (2023-07-01)

Combined Atlas and Convolutional Neural Network-Based Segmentation of the Hippocampus from MRI According to the ADNI Harmonized Protocol
by: Samaneh Nobakht, et al.
Published: (2021-04-01)

Pairwise Correlation Analysis of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation
by: Erik D. Huckvale, et al.
Published: (2021-10-01)

Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer's Disease Neuroimaging (ADNI) database.
by: Juan Felipe Beltrán, et al.
Published: (2020-01-01)

A longitudinal study of atrophy in amnestic mild cognitive impairment and normal aging revealed by cortical thickness.
by: Zhijun Yao, et al.
Published: (2012-01-01)

Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.
by: Bolun Li, et al.
Published: (2016-01-01)

How random is the random forest? Random forest algorithm on the service of structural imaging biomarkers for Alzheimer's disease: from Alzheimer's disease neuroimaging initiative (ADNI) database
by: Stavros I Dimitriadis, et al.
Published: (2018-01-01)

Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
by: Daniel Johnstone, et al.
Published: (2012-01-01)

CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia.
by: Pan Fu, et al.
Published: (2022-01-01)

Disrupted Patterns of Rich-Club and Diverse-Club Organizations in Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment
by: Chen Xue, et al.
Published: (2020-10-01)

Random forest model for feature-based Alzheimer's disease conversion prediction from early mild cognitive impairment subjects.
by: Matthew Velazquez, et al.
Published: (2021-01-01)

Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study.
by: Christopher Bryant, et al.
Published: (2013-01-01)

A combination of 3-D discrete wavelet transform and 3-D local binary pattern for classification of mild cognitive impairment
by: Harsh Bhasin, et al.
Published: (2020-02-01)

The impact of subthreshold levels of amyloid deposition on conversion to dementia in patients with amyloid-negative amnestic mild cognitive impairment
by: Hyung-Ji Kim, et al.
Published: (2022-07-01)

Sociodemographic data and APOE-ε4 augmentation for MRI-based detection of amnestic mild cognitive impairment using deep learning systems.
by: Obioma Pelka, et al.
Published: (2020-01-01)

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
by: Luise Christine Löwe, et al.
Published: (2016-01-01)

Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment
by: Matteo De Marco, et al.
Published: (2023-05-01)

Brain Entropy Mapping in Healthy Aging and Alzheimer’s Disease
by: Ze Wang, et al.
Published: (2020-11-01)

Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach
by: Xiwu Wang, et al.
Published: (2023-03-01)

Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort
by: Wang Cong, et al.
Published: (2017-05-01)

White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease.
by: Jared Rowley, et al.
Published: (2013-01-01)

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI.
by: Sid E O'Bryant, et al.
Published: (2011-01-01)

Development and validation of language and visuospatial composite scores in ADNI
by: Seo‐Eun Choi, et al.
Published: (2020-01-01)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
by: Giulia Arenare, et al.
Published: (2023-08-01)

FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
by: Anna Rubinski, et al.
Published: (2020-10-01)

Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB
by: Samira Jamalian, et al.
Published: (2023-07-01)

The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.
by: Tetsuro Sekine, et al.
Published: (2020-01-01)

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease
by: Yi Chen, et al.
Published: (2021-12-01)

Lower functional hippocampal redundancy in mild cognitive impairment
by: Stephanie Langella, et al.
Published: (2021-01-01)

The Relationship Between Hippocampal Volumes and Delayed Recall Is Modified by APOE ε4 in Mild Cognitive Impairment
by: Xiwu Wang, et al.
Published: (2019-02-01)

Effects of Smoking on Regional Homogeneity in Mild Cognitive Impairment: A Resting-State Functional MRI Study
by: Tianyi Zhang, et al.
Published: (2020-11-01)

Quick assessment for systematic test statistic inflation/deflation due to null model misspecifications in genome-wide environment interaction studies.
by: Masao Ueki, et al.
Published: (2019-01-01)

Imputation-Based Variable Selection Method for Block-Wise Missing Data When Integrating Multiple Longitudinal Studies
by: Zhongzhe Ouyang, et al.
Published: (2024-03-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
by: Guanan Zhao, et al.
Published: (2024-01-01)

Identification of Disease-Related Genes That Are Common between Alzheimer’s and Cardiovascular Disease Using Blood Genome-Wide Transcriptome Analysis
by: Taesic Lee, et al.
Published: (2021-10-01)

A Novel Coupling Model of Physiological Degradation and Emotional State for Prediction of Alzheimer’s Disease Progression
by: Jiawei Yang, et al.
Published: (2022-08-01)

Fast score test with global null estimation regardless of missing genotypes.
by: Shuntaro Sato, et al.
Published: (2018-01-01)

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
by: Yeonwoo Chung, et al.
Published: (2021-07-01)